Fingerprint
Dive into the research topics of 'Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide
Louise Justesen Hesselbjerg, Heidi Sjoelund Pedersen, Mikael Bergholdt Asmussen, Karin Dam Petersen
Research output: Contribution to journal › Journal article › Research › peer-review
4
Citations
(Scopus)